Celldex Therapeutics Inc New
CLDX
$21.35+1.82 (+9.32%)
Jun 7, 2025, 4:00 PM
Financials
| 52Week High | 47.00 | 52Week Low | 14.40 |
| Beta | 1.23 | Current Ratio Annual | 18.91 |
| Current Ratio Quarterly | 21.67 | Gross Margin TTM | 17.65 |
| Market Cap | 1.42B | Net Profit Margin TTM | -2,366.07 |
| Operating Margin TTM | -2,873.52 | Price To Book | 2.02 |
| Price To Free Cash Flow TTM | 45.52 | Price To Sales TTM | 187.53 |
| Quick Ratio Annual | 18.38 | Quick Ratio Quarterly | 21.06 |
| Return On Assets TTM | -22.35 | Return On Equity TTM | -23.46 |
| Return On Investment TTM | -23.46 | Revenue Growth3Y | 14.72 |
| Revenue Growth5Y | 14.48 | Revenue Growth Quarterly Yoy | 345.51 |
| Revenue Growth TTMYoy | 24.39 | Revenue Per Share TTM | 0.11 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 184 | 0 | 0 | 3 | 2 | 1 | 75.18M | $1.76B |
| Mar 31, 2025 | 174 | 26 | 37 | 60 | 59 | 25 | 74.02M | $1.27B |
| Change | 10(5%) | 26 | 37 | 57(1900%) | 57(2850%) | 24(2400%) | 1.16M(2%) | $483.13M(28%) |